Review: taking Naproxen sodium and Methylprednisolone together


Summary

Drug interactions are reported among people who take Naproxen sodium and Methylprednisolone together. This review analyzes the effectiveness and drug interactions between Naproxen sodium and Methylprednisolone. It is created by eHealthMe based on reports of 704 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Naproxen sodium and Methylprednisolone >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Naproxen Sodium

Naproxen sodium has active ingredients of naproxen sodium. It is often used in pain. (latest outcomes from Naproxen sodium 4,178 users)

Methylprednisolone

Methylprednisolone has active ingredients of methylprednisolone. It is often used in rheumatoid arthritis. (latest outcomes from Methylprednisolone 21,915 users)

On Aug, 22, 2016

704 people who take Naproxen Sodium, Methylprednisolone are studied.


Number of reports submitted per year:

Naproxen sodium and Methylprednisolone drug interactions.

Drug effectiveness over time:

Naproxen Sodium:
  • < 1 month: 0.0% - (0 of 6 people)
  • 1 - 6 months: 33.0% - (1 of 3 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 1 people)
Methylprednisolone:
  • < 1 month: 33.0% - (3 of 9 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 1 people)

Drug effectiveness by gender:

Naproxen Sodium:
  • female: 0.0% - (0 of 7 people)
  • male: 20.0% - (1 of 5 people)
Methylprednisolone:
  • female: 33.0% - (2 of 6 people)
  • male: 25.0% - (1 of 4 people)

Drug effectiveness by age:

Naproxen Sodium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 5 people)
  • 40-49: 16.0% - (1 of 6 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Methylprednisolone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 25.0% - (1 of 4 people)
  • 40-49: 40.0% - (2 of 5 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • pneumonia
  • demyelinating polyneuropathy
  • dyspnoea
  • pruritus
  • acute graft versus host disease in skin
  • asthenia
  • diverticulitis
  • haemoglobin decreased
  • hypertension
  • overdose
1 - 6 months:
  • hip fracture
  • osteopenia
  • pain
  • rib fracture
  • stress fracture
  • bone density decreased
  • acute graft versus host disease in skin
  • pseudomonal sepsis
  • acute myeloid leukaemia recurrent
  • acute myeloid leukaemia
6 - 12 months:
  • hip fracture
  • osteopenia
  • pain
  • rib fracture
  • stress fracture
  • bone density decreased
  • anxiety
  • depression
  • stress
  • bruxism
1 - 2 years:
  • anxiety
  • back injury
  • chest injury
  • confusional state
  • constipation
  • depression
  • disturbance in attention
  • escherichia infection
  • flatulence
  • gastrointestinal disorder
2 - 5 years:
  • anxiety
  • depression
  • malignant melanoma
  • autoimmune hepatitis
  • disturbance in attention
  • hepatitis acute
  • loss of consciousness
  • suicidal ideation
  • suicide attempt
  • alcohol abuse
5 - 10 years:
  • anxiety
  • back pain
  • depression
  • erysipelas
  • liver function test abnormal
  • viral infection
  • bipolar disorder
  • emotional distress
  • injury
  • pain
not specified:
  • pain
  • anxiety
  • injury
  • arthralgia
  • back pain
  • hypoaesthesia
  • fatigue
  • osteonecrosis of jaw
  • osteoarthritis
  • pain in extremity

Most common drug interactions by gender *:

female:
  • pain
  • anxiety
  • back pain
  • injury
  • osteonecrosis of jaw
  • hypoaesthesia
  • osteoarthritis
  • fatigue
  • pain in extremity
  • arthralgia
male:
  • arthralgia
  • pain
  • anxiety
  • constipation
  • fatigue
  • injury
  • back pain
  • malaise
  • nausea
  • depression

Most common drug interactions by age *:

2-9:
  • arthritis
  • rheumatoid arthritis
  • disease progression
  • juvenile arthritis
  • rheumatoid nodule
  • abdominal pain
  • cellulitis
  • constipation
  • haematochezia
  • hepatitis acute
10-19:
  • multi-organ failure
  • arthralgia
  • balance disorder
  • brain oedema
  • disseminated intravascular coagulation
  • drug rash with eosinophilia and systemic symptoms
  • fall
  • general physical health deterioration
  • hepatic encephalopathy
  • hepatitis acute
20-29:
  • injury
  • pain
  • cholelithiasis
  • cholecystitis chronic
  • pulmonary embolism
  • anxiety
  • deep vein thrombosis
  • depression
  • nausea
  • acute graft versus host disease in skin
30-39:
  • deep vein thrombosis
  • pulmonary embolism
  • injury
  • pain
  • pain in extremity
  • abdominal pain
  • emotional distress
  • anxiety
  • nausea
  • dyspnoea
40-49:
  • pain
  • fatigue
  • chest pain
  • rib fracture
  • anxiety
  • diabetes mellitus
  • osteopenia
  • bone density decreased
  • pneumonia
  • hip fracture
50-59:
  • arthralgia
  • osteoarthritis
  • back pain
  • pain
  • fatigue
  • spinal osteoarthritis
  • osteonecrosis of jaw
  • injury
  • decreased appetite
  • nausea
60+:
  • pain
  • anxiety
  • osteoarthritis
  • spinal osteoarthritis
  • impaired healing
  • back pain
  • bone disorder
  • osteomyelitis
  • pain in extremity
  • headache

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Naproxen sodium and Methylprednisolone?

Can you answer these questions?

More questions for: Naproxen sodium, Methylprednisolone

You may be interested in these reviews

More reviews for: Naproxen sodium, Methylprednisolone

On eHealthMe, Naproxen sodium (naproxen sodium) is often used to treat pain. Methylprednisolone (methylprednisolone) is often used to treat rheumatoid arthritis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.